These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 6932939)
1. Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities. Siemann DW Br J Cancer Suppl; 1980 Apr; 4():294-8. PubMed ID: 6932939 [TBL] [Abstract][Full Text] [Related]
2. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents. Stephens TC; Peacock JH Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938 [TBL] [Abstract][Full Text] [Related]
3. Radiobiological studies of tumours in situ compared with cell survival. McNally NJ; de Ronde J Br J Cancer Suppl; 1980 Apr; 4():259-65. PubMed ID: 6932934 [TBL] [Abstract][Full Text] [Related]
4. The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo. Kerr DJ; Smart HE In Vivo; 1991; 5(4):385-8. PubMed ID: 1810425 [TBL] [Abstract][Full Text] [Related]
5. Analysis of growth delay data: potential pitfalls. Begg AC Br J Cancer Suppl; 1980 Apr; 4():93-7. PubMed ID: 6932951 [TBL] [Abstract][Full Text] [Related]
6. Can dose-survival parameters be deduced from in situ assays? Wheldon TE Br J Cancer Suppl; 1980 Apr; 4():79-87. PubMed ID: 7000126 [TBL] [Abstract][Full Text] [Related]
7. The effect of recovery from potentially lethal damage on the determination of reoxygenation in a murine tumour. Sheldon PW; Fowler JF Br J Radiol; 1979 Aug; 52(620):634-41. PubMed ID: 486893 [TBL] [Abstract][Full Text] [Related]
8. Is cell survival a determinant of the in situ response of 9L tumours? Wheeler KT; Wallen CA Br J Cancer Suppl; 1980 Apr; 4():299-303. PubMed ID: 6932940 [TBL] [Abstract][Full Text] [Related]
11. Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statistics. Wheldon TE; Brunton GF Br J Cancer; 1982 Jan; 45(1):1-9. PubMed ID: 7059451 [TBL] [Abstract][Full Text] [Related]
12. Interaction between bisantrene and radiation. Hernandez E; Rosenshein NB Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1395-9. PubMed ID: 4008295 [TBL] [Abstract][Full Text] [Related]
13. Influence of tumour size on radiosensitization by misonidazole. Stanley JA; Peckham MJ; Steel GG Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232 [TBL] [Abstract][Full Text] [Related]
14. Response of murine small intestine to combined treatment with fostriecin and X rays. Rao KR; Fritz-Niggli H Br J Radiol; 1990 Apr; 63(748):286-9. PubMed ID: 2346866 [TBL] [Abstract][Full Text] [Related]
15. Dose fractionation effects in plateau-phase cultures of C3H 10T1/2 cells and their transformed counterparts. Zeman EM; Bedford JS Radiat Res; 1985 Feb; 101(2):373-93. PubMed ID: 3975362 [TBL] [Abstract][Full Text] [Related]
16. Relationship of clonogenic cells and "tumour-rescuing cells", modelled in irradiated spheroids in vitro. Moore JV; Hendry JH Br J Radiol; 1984 Oct; 57(682):935-7. PubMed ID: 6487967 [No Abstract] [Full Text] [Related]
17. An isoeffect approach to the study of combined effects of mixed radiations--the nonparametric analysis of in vivo data. Lam GK Radiat Res; 1989 Sep; 119(3):424-31. PubMed ID: 2772135 [TBL] [Abstract][Full Text] [Related]
18. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Rupnow BA; Murtha AD; Alarcon RM; Giaccia AJ; Knox SJ Cancer Res; 1998 May; 58(9):1779-84. PubMed ID: 9581811 [TBL] [Abstract][Full Text] [Related]
19. Reoxygenation of hypoxic tumour cells. van Putten LM Strahlentherapie; 1977 Jun; 153(6):380-3. PubMed ID: 877974 [TBL] [Abstract][Full Text] [Related]
20. The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor model. Phillips RM; Bibby MC; Double JA; Loadman PM Int J Cell Cloning; 1991 Mar; 9(2):144-54. PubMed ID: 2037811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]